Renaissance Capital logo

CMMB News

US IPO Weekly Recap: Blue jeans are back as Levi's preps March IPO

VTUS

Levi Strauss (LEVI) is bringing its blue jeans back to public markets. This week the company filed for an IPO that we estimate could raise $750 million, coming as early as March. It's no wonder Levi is going public, based on its 2017 and 2018...read more

Micro-cap biotech Anchiano Therapeutics prices IPO at $11.50, below the expected price

Chemomab Therapeutics (Anchiano) logo

Anchiano Therapeutics, a late-stage biotech developing therapies for early-stage bladder cancer, raised $31 million by offering 2.7 million ADSs at $11.50, below the expected price of $14.55. At $11.50, Anchiano Therapeutics would command a market cap of...read more

US IPO Week Ahead: On track for 7 IPOs, led by Virgin Trains USA

VTUS

Railroad IPOs were hot in the 1850's, but two billionaires are bringing the industry back this week with an offering of Virgin Trains USA. In total, the week could see up to seven deals, but Virgin Trains USA's $510 million IPO is larger than the other six...read more

Micro-cap biotech Anchiano Therapeutics sets terms for $35 million US IPO

Chemomab Therapeutics (Anchiano) logo

Anchiano Therapeutics, a Phase 3 biotech developing therapies for early-stage bladder cancer, announced terms for its IPO on Thursday. The Jerusalem, Israel-based company plans to raise $35 million by offering 2.4 million ADSs at a price of $14.55, the...read more